Publications:

MLKL and other necroptosis-related genes promote the tumor immune cell infiltration, guiding for the administration of immunotherapy in bladder urothelial carcinoma.

Apoptosis : An International Journal On Programmed Cell Death

Zhong, Boqiang B; Wang, Youzhi Y; Liao, Yihao Y; Liang, Jiaming J; Wang, Keke K; Zhou, Diansheng D; Zhao, Yang Y; Jiang, Ning N

Publication Date: 2023-03-31

Variant appearance in text: CD4: A43P

PubMed Link: 37000317

Variant Present in the following documents:

• 10495_2023_1830_MOESM19_ESM.xlsx, sheet 6

View BVdb publication page

Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature.

Frontiers In Oncology

Wang, Wenhao W; Hua, Shan S; Li, Jianying J; Zhao, Jing J; Zhang, Yu Y; Jiang, Juntao J; Han, Bangmin B

Publication Date: 2022

Variant appearance in text: CD4: A43P

PubMed Link: 36620542

Variant Present in the following documents:

• Table_3.xlsx, sheet 1

View BVdb publication page

Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria.

American Journal Of Human Genetics

Pejaver, Vikas V; Byrne, Alicia B AB; Feng, Bing-Jian BJ; Pagel, Kymberleigh A KA; Mooney, Sean D SD; Karchin, Rachel R; O'Donnell-Luria, Anne A; Harrison, Steven M SM; Tavtigian, Sean V SV; Greenblatt, Marc S MS; Biesecker, Leslie G LG; Radivojac, Predrag P; Brenner, Steven E SE; ,

Publication Date: 2022-12-01

Variant appearance in text: CD4: A43P; rs1401043905

PubMed Link: 36413997

Variant Present in the following documents:

• mmc3.xlsx, sheet 1

View BVdb publication page

OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts.

Frontiers In Oncology

Lin, Jiaxing J; Xu, Xiao X; Li, Tianren T; Yao, Jihang J; Yu, Meng M; Zhu, Yuyan Y; Sun, Dan D

Publication Date: 2021

Variant appearance in text: CD4: A43P

PubMed Link: 34868901

Variant Present in the following documents:

• Table_1.xlsx, sheet 6

View BVdb publication page

Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis.

Biomed Research International

Ma, Yao Y; Feng, Xiao-Fei XF; Yang, Wan-Xia WX; You, Chong-Ge CG

Publication Date: 2019

Variant appearance in text: CD4: A43P

PubMed Link: 31534952

Variant Present in the following documents:

• BMRI2019-1093815.pdf

View BVdb publication page